News
Insights
Jobs
Career Advice
Companies
Hotbeds
More

SUBSCRIBE

SUBSCRIBE

News
Insights
Jobs
Career Advice
Companies
Hotbeds
More

Search Query

Search Results

Looking for jobs? Search jobs

16,363 Results

Type

Article (897)
Company Profile (3)
Press Release (15463)

Section

Business (3638)
Career Advice (5)
Deals (533)
Drug Development (5310)
Employer Resources (1)
FDA (497)
Job Trends (705)
News (9485)
Policy (726)

Tag

Date

Last 7 days (18)
Last 30 days (71)
Last 365 days (1459)
2025 (58)
2024 (1477)
2023 (1592)
2022 (1751)
2021 (1746)
2020 (1568)
2019 (1317)
2018 (1056)
2017 (949)
2016 (863)
2015 (918)
2014 (611)
2013 (449)
2012 (336)
2011 (346)
2010 (240)

Location

Africa (9)
Asia (1352)
Australia (333)
California (143)
Canada (75)
China (38)
Colorado (11)
Connecticut (7)
Delaware (19)
Europe (3528)
Florida (12)
Illinois (9)
Indiana (12)
Japan (14)
Maryland (19)
Massachusetts (92)
Minnesota (9)
Montana (9)
Nevada (3)
New Jersey (83)
New York (69)
North Carolina (16)
Northern California (66)
Pennsylvania (25)
South America (11)
Southern California (61)
Texas (16)
Utah (10)
Washington State (15)

Filters

Type

Article (897)
Company Profile (3)
Press Release (15463)

Section

Business (3638)
Career Advice (5)
Deals (533)
Drug Development (5310)
Employer Resources (1)
FDA (497)
Job Trends (705)
News (9485)
Policy (726)

Tag

Date

Last 7 days (18)
Last 30 days (71)
Last 365 days (1459)
2025 (58)
2024 (1477)
2023 (1592)
2022 (1751)
2021 (1746)
2020 (1568)
2019 (1317)
2018 (1056)
2017 (949)
2016 (863)
2015 (918)
2014 (611)
2013 (449)
2012 (336)
2011 (346)
2010 (240)

Location

Africa (9)
Asia (1352)
Australia (333)
California (143)
Canada (75)
China (38)
Colorado (11)
Connecticut (7)
Delaware (19)
Europe (3528)
Florida (12)
Illinois (9)
Indiana (12)
Japan (14)
Maryland (19)
Massachusetts (92)
Minnesota (9)
Montana (9)
Nevada (3)
New Jersey (83)
New York (69)
North Carolina (16)
Northern California (66)
Pennsylvania (25)
South America (11)
Southern California (61)
Texas (16)
Utah (10)
Washington State (15)

16,363 Results for "ose immunotherapeutics".

Sort By

Press Releases

OSE Immunotherapeutics Appoints Dr. Sonya Montgomery as Chief Development Officer

January 14, 2025
·
5 min read
Press Releases

OSE Immunotherapeutics Strengthens Leadership and Executive Committee

December 3, 2024
·
8 min read
Business

OSE Immunotherapeutics Provides Business and Corporate Update

OSE Immunotherapeutics Provides Business and Corporate Update Three pharmaceutical agreements signed during the last three months.

May 30, 2024
·
12 min read
Press Releases

OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’

OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’

July 1, 2024
·
9 min read
Business

OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell Therapies

OSE Immunotherapeutics SA, announced that the Company has entered into a commercial and revenue sharing agreement with leading global cancer center.

June 24, 2024
·
6 min read
Business

OSE Immunotherapeutics Reports on its 2024 General Shareholders’ Meeting and the Evolution of the Board of Directors Ready to Drive the Strategic Company’s Growth

OSE Immunotherapeutics SA announced that all the resolutions submitted to a vote at the Combined General Shareholders’ Meeting were approved as proposed by OSE Immunotherapeutics’ Board of Directors.

June 19, 2024
·
15 min read
Press Releases

OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage Proprietary Cancer Vaccine Tedopi®

December 11, 2024
·
6 min read
Business

OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseases

OSE Immunotherapeutics SA and Boehringer Ingelheim announced a major expansion of their partnership.

May 22, 2024
·
9 min read
Press Releases

OSE Immunotherapeutics to Present Anti-IL-7R Lusvertikimab Phase 2 Induction Results in Ulcerative Colitis at 20th Congress of ECCO

December 19, 2024
·
8 min read
OSE Immunotherapeutics’ Global License to Develop a Novel Monoclonal Antibody for the Treatment of Chronic Inflammation Becomes Effective

OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today announced that the Hart-Scott-Rodino waiting period has expired with respect to its global license with AbbVie to develop OSE-230, a monoclonal antibody designed to resolve chronic and severe inflammation, currently in the pre-clinical development stage.

April 16, 2024
·
5 min read

1 of 1,637

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.

Explore
About
More

© 1985 - 2025 BioSpace.com. All rights reserved.

twitter
instagram
facebook
linkedin